SCHEMBL12820489

SCHEMBL12820489

CNCCNC(=O)[C@H]1CC[C@H](Nc2cc(-c3c4n(c5cc(F)ccc35)C(=O)CC(C)(C)C4)cc(F)c2C(N)=O)CC1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 18/20 0.38
HSP90AB1 P08238 18/20 0.38
HSP90B1 P14625 6/20 0.38
TRAP1 Q12931 5/20 0.38
GRM2 Q14416 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12820156 0.94 HSP90AA1 (0.39) HSP90AA1HSP90AB1HSP90B1TRAP1GRM2
SCHEMBL12820130 0.92 MELK (0.38) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12819775 0.92 HSP90AA1 (0.40) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12820382 0.91 HSP90AA1 (0.39) HSP90AA1HSP90AB1HSP90B1TRAP1GRM2
SCHEMBL12819934 0.90 HSP90AA1 (0.37) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12820438 0.90 HSP90AA1 (0.37) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12820128 0.89 HSP90AA1 (0.31) HSP90AA1HSP90AB1MTNR1AMTNR1B
SCHEMBL12820042 0.89 HSP90AA1 (0.43) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12819737 0.89 HSP90AA1 (0.41) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL12820015 0.88 HSP90AA1 (0.42) HSP90AA1HSP90AB1HSP90B1TRAP1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012126084-A1 HSP-90 BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE IΝ THE TREATMENT AND PREVENTION OF FUNGAL INFECTIONS PHARMASCIENCE INC. (CA) 2012-09-27 WO disclosed
WO-2011035417-A1 HSP-90 BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE FN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AEGERA THERAPEUTICS INC. (CA) 2011-03-31 WO disclosed